{"organizations": [], "uuid": "ef10cad142c8bd5c78e25c04d698ca065b383e3a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-celyad-to-present-updates-on-cyad/brief-celyad-to-present-updates-on-cyad-01-at-american-association-for-cancer-research-annual-meeting-idUSFWN1RA120", "country": "US", "domain_rank": 408, "title": "BRIEF-Celyad To Present Updates On CYAD-01 At American Association For Cancer Research Annual Meeting", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-29T08:14:00.000+03:00", "replies_count": 0, "uuid": "ef10cad142c8bd5c78e25c04d698ca065b383e3a"}, "author": "", "url": "https://www.reuters.com/article/brief-celyad-to-present-updates-on-cyad/brief-celyad-to-present-updates-on-cyad-01-at-american-association-for-cancer-research-annual-meeting-idUSFWN1RA120", "ord_in_thread": 0, "title": "BRIEF-Celyad To Present Updates On CYAD-01 At American Association For Cancer Research Annual Meeting", "locations": [], "entities": {"persons": [{"name": "celyad", "sentiment": "none"}], "locations": [], "organizations": [{"name": "american association for cancer research annual", "sentiment": "negative"}, {"name": "american association", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "cancer research annual meeting reuters", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 29, 2018 / 5:16 AM / in 13 minutes BRIEF-Celyad To Present Updates On CYAD-01 At American Association For Cancer Research Annual Meeting Reuters Staff 1 Min Read \nMarch 29 (Reuters) - CELYAD SA: \n* CELYAD TO PRESENT UPDATES ON CYAD-01 AT THE AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) ANNUAL MEETING 2018 \n* ‍PRECLINICAL STUDY SHOWS ADDING CD28 OR 4-1BB TO CYAD-01 BRINGS NO BENEFIT FOR IN VITRO ACTIVITY OF RECEPTOR​ \n* TO PRESENT UPDATE FROM THINK TRIAL, NEW SHRINK AND LINK TRIALS IN METASTATIC COLORECTAL CANCER​ \n* ‍THINK TRIAL: PRELIMINARY EVIDENCE OF NKG2D CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY (CYAD-01) CLINICAL ACTIVITY​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)", "external_links": [], "published": "2018-03-29T08:14:00.000+03:00", "crawled": "2018-03-29T08:33:06.003+03:00", "highlightTitle": ""}